Dimethylformamide → HCID 71715942, compound
Reaction equation
[OH:1][C@@H:2]1[C@H:6]([OH:7])[C@@H:5]([CH2:8][O:9][S:10](=[O:13])(=[O:12])[NH2:11])[CH2:4][C@H:3]1[NH:14][C:15]1[N:20]2[N:21]=[C:22]([C:24]3[CH:33]=[CH:32][CH:31]=[C:30]4[C:25]=3[CH:26]=[CH:27][C:28]([C:34]([O:36]C)=[O:35])=[CH:29]4)[CH:23]=[C:19]2[N:18]=[CH:17][CH:16]=1.CN(C=O)C.[OH-].[Na+]>>[OH:1][C@@H:2]1[C@H:6]([OH:7])[C@@H:5]([CH2:8][O:9][S:10](=[O:13])(=[O:12])[NH2:11])[CH2:4][C@H:3]1[NH:14][C:15]1[N:20]2[N:21]=[C:22]([C:24]3[CH:33]=[CH:32][CH:31]=[C:30]4[C:25]=3[CH:26]=[CH:27][C:28]([C:34]([OH:36])=[O:35])=[CH:29]4)[CH:23]=[C:19]2[N:18]=[CH:17][CH:16]=1Participants
Procedure
To a solution of (rac)-methyl rel-5-[7-({(1R,2S,3R,4R)-2,3-dihydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl}amino)pyrazolo[1,5-a]pyrimidin-2-yl]-2-naphthoate (0.048 g, 0.091 mmol) in DMF (2.0 mL, 26 mmol) is added 1.0 M NaOH (1.0 mL, 1.0 mmol). The mixture is stirred at room temperature for 1.5 hr and then concentrated in vacuo as an azeotropic mixture with toluene. The crude material is purified by preparative HPLC to provide (rac)-rel-5-[7-({(1R,2S,3R,4R)-2,3-dihydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl}amino)pyrazolo[1,5-a]pyrimidin-2-yl]-2-naphthoic acid (4.0 mg, yield 8.5%). LCMS: (AA) M+1 514; 1H NMR (400 MHz, DMSO) δ 8.71-8.63 (m, 1H), 8.55 (d, J=8.9 Hz, 1H), 8.25-8.16 (m, 2H), 8.09-7.98 (m, 1H), 7.98-7.90 (m, 1H), 7.89-7.79 (m, 1H), 7.75-7.63 (m, 1H), 7.55-7.25 (m, 1H), 6.79 (s, 1H), 6.33 (d, J=5.4 Hz, 1H), 5.2-4.6 (m, 2H), 4.18-4.05 (m, 1H), 4.06-3.90 (m, 3H), 3.80-3.68 (m, 1H), 2.40-2.15 (m, 2H), 1.56-1.36 (m, 1H).
Workup
- concentrationconcentrated in vacuo as an azeotropic mixture with toluene
- customThe crude material is purified by preparative HPLC
Sources & evidence
- ORD record
- ord-eba7bfba2dc349ad817f8fd657c84322
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09290500B2
Reaction notes
Loading…